Healthcare & Life Sciences
Immusoft
United Statesimmusoft.com
Immusoft is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 2 tracked investors.
Activeseries-b
series-b
Stage
2
Investors
About Immusoft
Based in the United States, Immusoft is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Immusoft engineers patient-derived B cells to program them as plasma cells that produce therapeutic proteins, which are then infused back into patients to provide durable and personalized protein therapies.
Explore Immusoft's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.